Evidence map›Paper›PMID 41056200›Full record

ArticleStatistical methods in medical research2025

Assessing spillover effects: Handling missing outcomes in network-based studies.

TingFang Lee, Ashley L Buchanan, Natallia Katenka, Laura Forastiere, M Elizabeth Halloran, Georgios Nikolopoulos

Abstract read
In one paragraph

Article in Statistical methods in medical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

TingFang LeeDivision of Biostatistics, Department of Population Health, New York University Grossman School of Medicine, NY, USA.ORCID 0000-0003-4939-7136
Ashley L BuchananDepartment of Pharmacy Practice and Clinical Research, University of Rhode Island, Kingston, RI, USA.
Natallia KatenkaDepartment of Computer Science and Statistics, University of Rhode Island, Kingston, RI, USA.
Laura ForastiereSchool of Public Health, Yale University, New Haven, CT, USA.
M Elizabeth HalloranBiostatistics, Bioinformatics, and Epidemiology Program, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, and Department of Biostatistics, University of Washington, Seattle, WA, USA.
Georgios NikolopoulosMedical School, University of Cyprus, Nicosia, Cyprus.ORCID 0000-0002-3307-0246

Funding

Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI Holly Hagan, Courtney McKnight · 1998 to 2026
$38.9M
Causal Inference in Infectious Disease Prevention StudiesR01AI085073 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HUDGENS, MICHAEL G · 2010 to 2024
$4.5M
Preventing HIV Transmission by Recently-Infected Drug UsersDP1DA034989 · NIDA · NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES, INC. · PI FRIEDMAN, SAMUEL R · 2012 to 2016
$3.8M
Developing causal inference methods to evaluate and leverage spillover effects through social Interactions for designing improved HIV prevention interventionsR01MH134715 · NIMH · YALE UNIVERSITY · PI Laura Forastiere · 2023 to 2026
$3.1M
Causal Inference Methods for HIV Prevention Studies Among Networks of People Who Use DrugsDP2DA046856 · NIDA · UNIVERSITY OF RHODE ISLAND · PI BUCHANAN, ASHLEY LYNN · 2018 to 2019
$2.3M
Network-based study design, statistical, and modeling solutions for HIV among populations that use illicit substances: Informing interventions and policy in real-world settings using existing dataR01DA058994 · NIDA · UNIVERSITY OF RHODE ISLAND · PI Ashley Lynn Buchanan · 2024 to 2026
$2.2M
Causal Inference in Infectious Disease Prevention StudiesR37AI085073 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Michael G Hudgens · 2026 to 2026
$394k
NIAID NIH HHS R01 AI085073NIAID NIH HHS R37 AI085073NIDA NIH HHS DP1 DA034989NIDA NIH HHS DP2 DA046856NIDA NIH HHS P30 DA011041NIDA NIH HHS R01 DA058994NIMH NIH HHS R01 MH134715
6 · The paper itself

Abstract

Estimating causal effects in the presence of spillover among individuals within a social network poses challenges due to missing information. Spillover effects refer to the impact of an intervention on individuals not directly exposed themselves but connected to intervention recipients within the network. In network-based studies, outcomes may be missing due to study termination or participant dropout, termed censoring. We introduce an inverse probability censoring weighted estimator which extends the inverse probability weighted estimator for network-based observational studies to handle possible outcome censoring. We prove the consistency and asymptotic normality of the proposed estimator and derive a closed-form estimator for its asymptotic variance. Applying the inverse probability censoring weighted estimator, we assess spillover effects in a network-based study of a nonrandomized intervention with outcome censoring. A simulation study evaluates the finite-sample performance of the inverse probability censoring weighted estimator, demonstrating its effectiveness with sufficiently large sample sizes and number of connected subnetworks. We then employ the method to assess spillover effects of community alerts on self-reported human immunodeficiency virus risk behavior among people who inject drugs and their contacts in the Transmission Reduction Intervention Project (TRIP), from 2013 to 2015, Athens, Greece. Results suggest that community alerts may help reduce human immunodeficiency virus risk behavior for both the individuals who receive them and others in their network, possibly through shared information. In this study, we found that the risk of human immunodeficiency virus behavior was reduced by increasing the proportion of a participant's immediate contacts exposed to community alerts.

Indexed as

Models, StatisticalProbabilityCausalityComputer SimulationHIV InfectionsHumansRisk-TakingSubstance Abuse, IntravenousCausal inferencedissemination/spilloverHIV/AIDSinterferenceinverse probability weightsnetwork studiespeople who inject drugs

Identifiers

PMID41056200
PMCPMC13045634

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.